Eton Pharmaceuticals, Inc.
ETON
$58.83
-$0.52-0.87%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 37.59M | 24.27M | 21.28M | 22.46M | 18.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 37.59M | 24.27M | 21.28M | 22.46M | 18.93M |
| Cost of Revenue | 11.53M | 9.18M | 6.76M | 13.28M | 5.80M |
| Gross Profit | 26.06M | 15.09M | 14.52M | 9.18M | 13.13M |
| SG&A Expenses | 11.63M | 10.45M | 8.28M | 8.11M | 9.69M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 24.15M | 21.50M | 16.82M | 22.50M | 19.20M |
| Operating Income | 13.44M | 2.76M | 4.47M | -39.00K | -268.00K |
| Income Before Tax | 11.72M | 1.57M | 1.41M | -1.96M | -2.52M |
| Income Tax Expenses | 140.00K | 20.00K | -69.00K | -28.00K | 66.00K |
| Earnings from Continuing Operations | 11.58M | 1.55M | 1.48M | -1.93M | -2.59M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 11.58M | 1.55M | 1.48M | -1.93M | -2.59M |
| EBIT | 13.44M | 2.76M | 4.47M | -39.00K | -268.00K |
| EBITDA | 14.83M | 3.90M | 5.48M | 970.00K | 737.00K |
| EPS Basic | 0.42 | 0.06 | 0.06 | -0.07 | -0.10 |
| Normalized Basic EPS | 0.28 | 0.04 | 0.08 | -0.01 | -0.03 |
| EPS Diluted | 0.35 | 0.05 | 0.05 | -0.07 | -0.10 |
| Normalized Diluted EPS | 0.24 | 0.04 | 0.07 | -0.01 | -0.03 |
| Average Basic Shares Outstanding | 27.64M | 27.29M | 26.94M | 26.89M | 26.89M |
| Average Diluted Shares Outstanding | 32.79M | 31.55M | 31.24M | 26.89M | 26.89M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |